Cite Filings / CCCC / 0001628280-26-033865

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

C4 Therapeutics, Inc. Filed 2026-05-12 Acc 0001628280-26-033865

Documents 1

10-Q Quarterly Report , cccc-20260331.htm

Around this filing

2026-08-11 10-Q Quarterly Report
2026-05-15 8-K Executive or director change
2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-15 SCHEDULE 13G Statement of Beneficial Ownership
2026-05-12 10-Q Quarterly Report
2026-05-12 8-K Results of operations · Regulation FD disclosure
2025-11-06 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading cccc-20260331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…